The digene HPV Test (digene HC2 HPV DNA Test) has been approved in Europe and the United States since 1999. More than 300 peer-reviewed journal articles have data generated with the digene HPV Test, and the test has been studied in international clinical trials involving over 1 million women worldwide. The digene HPV Test is the world's most proven HPV test for sensitive, early detection of cervical cancer and disease.